Sitemap

• Welcome to singular mAb experience
• SYnAbs Singular Antibodies
• Immunoassays provider
• • MYstick, mouse isotyping kit
  • Residual protein A
  • Immunoaffinity columns
• Primary monoclonal antibodies
• • Anti-His tag antibodies
  • Anti-steroids antibodies
  • anti-DNP irrelevant antibodies
  • Isotype control antibodies
  • Anti-toxins antibodies
  • Anti-HRP, FITC, Biotin & Quenchers antibodies
  • Anti-pathogens antibodies
  • Anti-cytokines & anti-hormones antibodies
  • Anti-proteins antibodies
  • Anti-chemical compounds antibodies
• Secondary monoclonal antibodies
• • Anti-guinea pig antibodies
  • Anti-species antibodies
  • Anti-rabbit antibodies
  • Anti-human antibodies
  • Anti-rat antibodies
  • Anti-mouse antibodies
• Custom monoclonal antibody development
• • Aflatoxin antibodies
  • Carbohydrate-specific antibodies
  • Neo-epitopes antibodies
  • Epigenetic modifications antibodies
  • Therapeutic antibodies
  • Peptide biomarkers antibodies
  • Infectious diseases antibodies
  • Lipid antibodies
• SYnAbs multi-species immunization approach
• • Rat Monoclonal Antibodies
  • Guinea pig Monoclonal Antibodies
• About SynAbs
• • SynAbs recent news
  • • Distribution agreement
    • Congress
    • Organic growth
    • Technical breakthrough
  • A team of mAb experts
  • Distributors of SynAbs mAbs catalogue
  • Partners for one-stop-shop mAb solution
  • Contact SynAbs
  • Glossary and Frequently Asked Questions

Blog

• 08/07/2019 - SYnAbs enters in India!
• 07/04/2019 - Happy independence day to all our US friends on the behalf of SYnAbs team!
• 07/02/2019 - mAbexperts commits to the future of immunotherapy: Complete VHH-CAR-T design
• 06/26/2019 - Best tips to select an outsourcing provider for custom antibody generation
• 06/25/2019 - SYnAbs attended Pivotal Scientific congress in Oxford
• 06/10/2019 - Innovative anti-VHH antibodies : SYnAbs enters the nano-world
• 06/08/2019 - Innovative tools to boost your research on infectious diseases
• 05/20/2019 - SYnAbs in United Kingdom for antibody generation
• 05/15/2019 - mAbexperts attends Buzz4Bio outsourcing congress
• 05/08/2019 - SYnAbs at Knowledge For Growth
• 04/29/2019 - SYnAbs attends K4G on May 9th
• 04/27/2019 - The CAM family: a new target for monitoring or treating cancers?
• 04/25/2019 - SYnAbs attends Biotechnica Labvolution congress
• 04/20/2019 - SYnAbs and Univercells announce service agreement on biosimilar
• 04/19/2019 - Meet mAb Experts at AIS Congress
• 04/16/2019 - Why DNA immunization is still necessary?
• 04/12/2019 - Replacing in-vivo by an in-vitro test? Rabies mAb example
• 03/23/2019 - SYnAbs recherche de nouveaux talents
• 03/11/2019 - Neurogenic and SYnAbs deal for schizophrenia detection
• 02/05/2019 - mAb Experts attends Buzz4Bio congress in France
• 01/28/2019 - Horiba & SYnAbs partnership : Production of guinea pig monoclonal antibody directed against a steroid hormone and its binding study thanks to SPRi technology
• 01/15/2019 - ZenTech and SYnAbs sign strategic partnership agreement to generate innovative monoclonal antibodies targeting 8 hemoglobinopathia diseases
• 01/11/2019 - Happy New Year 2019!
• 11/28/2018 - SYnAbs: the launch of 3 innovative rat mAbs
• 11/14/2018 - SYnAbs is attending Medica congress
• 10/31/2018 - SYnAbs is at AusBiotech congress looking for Australian distributors
• 10/01/2018 - SYnAbs enters in Italy!
• 08/28/2018 - SYnAbs is proud to announce ISO 9001:2015 certification!
• 08/04/2018 - SYnAbs attended AACC congress in Chicago! Great success!
• 07/27/2018 - SYnAbs enters Chinese market!
• 06/25/2018 - SYnAbs is looking for new talents to expand its cell culture team
• 06/19/2018 - SYnAbs attended Pivotal Congress in Oxford
• 02/06/2018 - SYnAbs attended Buzz4Bio Cell&Gene Therapies
• 02/01/2018 - SYnAbs attended Innovation for Health in Rotterdam
• 01/24/2018 - SYnAbs launches mouse isotyping kit, MYstik™
• 01/24/2018 - SynAbs inks agreement with SKLM as new distributor for its unique catalogue of monoclonal antibodies in Morocco
• 01/17/2018 - SynAbs inks agreement with Theranostica as new distributor for its unique catalogue of monoclonal antibodies in Israël
• 12/14/2017 - SYnAbs/RD Biotech unique expertise in CAR-T cells
• 11/27/2017 - SynAbs, from UCL benches to Singapore
• 11/20/2017 - SynAbs attended Medica congress in Dusseldorf, Germany
• 10/24/2017 - SynAbs inks first distribution agreement in Asia
• 09/05/2017 - SynAbs widens its team to sustain organic growth
• 06/21/2017 - SynAbs attended Pivotal Scientific congress in Oxford!
• 06/01/2017 - SynAbs moves its facilities to Gosselies BioPark
• 05/24/2017 - SynAbs attended BioMed congress in Israël!
• 05/18/2017 - SynAbs attended Knowledge for Growth event in Ghent!
• 05/10/2017 - SynAbs attended WBC 10th anniversary as special guest!
• 05/05/2017 - SynAbs inks agreement with Sapphire as new distributor for its unique catalogue of monoclonal antibodies in USA & Canada
• 01/13/2017 - SynAbs inks agreement with Dianova GmbH as new distributor for its unique catalogue of monoclonal antibodies in Germany
• 09/19/2016 - SynAbs appoints LuBioScience GmbH as new distributor for its unique catalogue of monoclonal antibodies in Switzerland
• 08/03/2016 - Guinea pig monoclonal antibodies : a new promising tool for R&D, IVD and therapeutics
• 08/03/2016 - The small molecule detection challenge : the aflatoxin case study
• 01/28/2016 - SynAbs brings rats to antibody market
• 09/01/2015 - SynAbs set-up, a new rat mAb expert on the marketplace